Jeffrey L. Ives, Director at Acumen Pharmaceuticals, Inc. (ABOS), sold 81,098 shares at $6.48 ($526K) on 2023-08-17, disclosed to the SEC on 2023-08-18.
Scheduled sale ($526k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.48 | 39,149 | $254K | 48.2% |
| 2 | $6.48 | 39,149 | $254K | 48.2% |
| 3 | $6.66 | 2,800 | $19K | 3.5% |
| Total | $6.49 avg | 81,098 | $526K | 100% |
| Filing → |
| CARA | SELL | 2021-06-07 | $33K | — | Filing → |
| CARA | SELL | 2020-11-24 | $39K | — | Filing → |
| CARA | SELL | 2020-06-03 | $16K | — | Filing → |